ITIL-168 in Advanced Melanoma
Stopped early · Phase 2
Conditions studied: Advanced Cutaneous Melanoma
In brief
DELTA-1 is a phase 2 clinical trial to evaluate the efficacy and safety of ITIL-168 in adult subjects with advanced melanoma who have previously been treated with a PD-1 inhibitor. ITIL-168 is a cell therapy derived from a patient's own tumor-infiltrating immune cells (lymphocytes; TILs).
Key facts
- Study ID
- NCT05050006
- Run by
- Instil Bio
- People needed
- 29
- Starts
- 2021-10-07
- Expected to finish
- 2023-02-27
- Last updated by the study team
- 2024-04-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California San Diego, Moores Cancer Center — La Jolla, California, United States
- The Angeles Clinic and Research Institute — Los Angeles, California, United States
- USC - Norris Comprehensive Cancer Center — Los Angeles, California, United States
- UCLA Health - Westwood Cancer Care — Los Angeles, California, United States
- Stanford Cancer Institute — Stanford, California, United States
- University of Colorado - Anschutz Cancer Pavilion — Aurora, Colorado, United States
- Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- The University of Miami - Sylvester Comprehensive Cancer Center — Miami, Florida, United States
- Orlando Health Cancer Institute — Orlando, Florida, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- Rush University Cancer Center — Chicago, Illinois, United States
- Loyola University Chicago — Maywood, Illinois, United States
- University of Louisville, James Graham Brown Cancer Center — Louisville, Kentucky, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- University of Minnesota, Masonic Cancer Center — Minneapolis, Minnesota, United States
- Atlantic Health System - Morristown Medical Center — Morristown, New Jersey, United States
- Cleveland Clinic - Taussig Cancer Center — Cleveland, Ohio, United States
- St. Luke's University Health Network — Bethlehem, Pennsylvania, United States
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
- Princess Margaret Cancer Centre — Toronto, Ontario, Canada
- Cambridge University Hospital NHS Foundation Trust - Addenbrooke's Hospital — Cambridge, England, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.